16212211000001103: Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\UK product\Virtual medicinal product\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\UK product\Virtual therapeutic moiety\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\UK product\Virtual therapeutic moiety\Bicalutamide\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)

\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing bicalutamide\Bicalutamide\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing bicalutamide\Bicalutamide\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing bicalutamide\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)
\Medicinal product\Product manufactured as oral dose form\Product containing bicalutamide in oral dose form (medicinal product form)\Product containing only bicalutamide in oral dose form (medicinal product form)\Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet\Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Dec 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

2265471000001116 Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2265481000001119 Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57145401000001112 Bicalutamide 150mg tablets (Ranbaxy (UK) Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
57145501000001111 Bicalutamide 150mg tablets (Ranbaxy (UK) Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Is a	Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Has active ingredient	Bicalutamide	false	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Has specific active ingredient	Bicalutamide	true	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.) 28 tablet	Has AMP	True	Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2265471000001116	Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
2265481000001119	Bicalutamide 150mg tablets (Sun Pharmaceutical Industries Europe B.V.) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
57145401000001112	Bicalutamide 150mg tablets (Ranbaxy (UK) Ltd) (product)	en	Fully specified name	Inactive	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
57145501000001111	Bicalutamide 150mg tablets (Ranbaxy (UK) Ltd)	en	Synonym	Inactive	Entire term case sensitive	SNOMED CT United Kingdom drug extension module